Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor

Journal article

Steven P Jones, Michael F Gibson, David M Rimmer 3rd, Terrie M Gibson, Brent R Sharp, David J Lefer
J Am Coll Cardiol, vol. 40(6), 2002, pp. 1172–8

DOI: 10.1016/s0735-1097(02)02115-0

Cite

APA Click to copy
Jones, S. P., Gibson, M. F., 3rd, D. M. R., Gibson, T. M., Sharp, B. R., & Lefer, D. J. (2002). Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor. J Am Coll Cardiol, 40(6), 1172–1178. https://doi.org/10.1016/s0735-1097(02)02115-0

Chicago/Turabian Click to copy
Jones, Steven P, Michael F Gibson, David M Rimmer 3rd, Terrie M Gibson, Brent R Sharp, and David J Lefer. “Direct Vascular and Cardioprotective Effects of Rosuvastatin, a New HMG-CoA Reductase Inhibitor.” J Am Coll Cardiol 40, no. 6 (2002): 1172–8.

MLA Click to copy
Jones, Steven P., et al. “Direct Vascular and Cardioprotective Effects of Rosuvastatin, a New HMG-CoA Reductase Inhibitor.” J Am Coll Cardiol, vol. 40, no. 6, 2002, pp. 1172–78, doi:10.1016/s0735-1097(02)02115-0.

BibTeX Click to copy

@article{steven2002a,
  title = {Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor},
  year = {2002},
  issue = {6},
  journal = {J Am Coll Cardiol},
  pages = {1172–8},
  volume = {40},
  doi = {10.1016/s0735-1097(02)02115-0},
  author = {Jones, Steven P and Gibson, Michael F and 3rd, David M Rimmer and Gibson, Terrie M and Sharp, Brent R and Lefer, David J}
}